Tipus de document
InformeVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/228684
The CB2R–OX2R heteromer as a new therapeutic target to combat Alzheimer’s disease
Títol de la revista
Autors
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Alzheimer’s disease is a severe neurodegenerative disorder that affects approximately 5% of the European population, a percentage that increases substantially among the elderly. It is also the leading cause of dementia in older adults, accounting for more than 60% of cases.
Moreover, it affects not only the individual suffering from the disease but also the patient’s environment—family, friends, and acquaintances—resulting in a significant economic burden. For these reasons, Alzheimer’s disease represents a major public health issue, which becomes even more evident considering the ageing of the population.
Descripció
Summary of the work awarded with the first prize of the First edition of the UB Dr. Antoni i Subirana Chair Award for Research in Pharmacology for the best Master's Degree in Research in Pharmacology at the University of Barcelona
Matèries
Matèries (anglès)
Citació
Citació
BADIA FERNÀNDEZ, Pau. The CB2R–OX2R heteromer as a new therapeutic target to combat Alzheimer’s disease. [consulted: 9 of September of 2026]. Available at: https://hdl.handle.net/2445/228684